Discovery of XT1061, a HBV Capsid Assembly Modulator, as a Promising Therapeutic Candidate for Clinical Treatment of HBV Infection
Hepatitis B virus (HBV) persists as a major unresolved infectious disease. Patients typically require lifelong administration of nucleos(t)ide analogs (NAs) or interferons but seldom achieve functional cure. Recent studies indicate that HBV core assembly modulators (CAMs), when combined with NAs and interferons, can...